- Home
- PROK vs RMBI Comparison
PROK vs RMBI Comparison
Compare PROK & RMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- RMBI
- Stock Information
- Founded
- PROK 2015
- RMBI 1887
- Country
- PROK United States
- RMBI United States
- Employees
- PROK N/A
- RMBI N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- RMBI Major Banks
- Sector
- PROK Health Care
- RMBI Finance
- Exchange
- PROK Nasdaq
- RMBI Nasdaq
- Market Cap
- PROK 126.8M
- RMBI 128.3M
- IPO Year
- PROK N/A
- RMBI 2019
- Fundamental
- Price
- PROK $0.84
- RMBI $12.72
- Analyst Decision
- PROK Buy
- RMBI
- Analyst Count
- PROK 4
- RMBI 0
- Target Price
- PROK $5.00
- RMBI N/A
- AVG Volume (30 Days)
- PROK 434.6K
- RMBI 28.5K
- Earning Date
- PROK 05-09-2025
- RMBI 04-24-2025
- Dividend Yield
- PROK N/A
- RMBI 4.73%
- EPS Growth
- PROK N/A
- RMBI 1.10
- EPS
- PROK N/A
- RMBI 0.92
- Revenue
- PROK $76,000.00
- RMBI $42,915,048.00
- Revenue This Year
- PROK N/A
- RMBI N/A
- Revenue Next Year
- PROK N/A
- RMBI N/A
- P/E Ratio
- PROK N/A
- RMBI $13.86
- Revenue Growth
- PROK N/A
- RMBI 2.81
- 52 Week Low
- PROK $0.80
- RMBI $10.15
- 52 Week High
- PROK $4.44
- RMBI $15.15
- Technical
- Relative Strength Index (RSI)
- PROK 29.40
- RMBI 47.92
- Support Level
- PROK $0.87
- RMBI $12.53
- Resistance Level
- PROK $1.00
- RMBI $13.05
- Average True Range (ATR)
- PROK 0.10
- RMBI 0.38
- MACD
- PROK 0.01
- RMBI 0.06
- Stochastic Oscillator
- PROK 14.70
- RMBI 50.72
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans.